MYL

3 Big Pharma Stocks Under Pressure From Washington

We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed. More 

5 Healthcare Stocks Poised to Trump Q3 Earnings

Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat More 

Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America

Valeant Pharmaceuticals have made bad choices that have punished VRX stock holders. But those investors are hardly alone anymore. More 

Mylan NV (MYL) Stock Holders Can Shrug Off Kaleo’s EpiPen Threat

MYL isn't in trouble after Kaleo's announcement because Mylan stock has already accounted for the damage done by lower EpiPen sales. More 

Auvi-Q: Inexpensive EpiPen Rival Coming in 2017

Kaleo Pharmaceuticals is releasing the Auvi-Q once again, which is a cheaper alternative to the EpiPen, which has become quite expensive. More 

7 Pharmaceuticals Stocks to Sell Now

This week, 7 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

The Mylan NV (MYL) Stock Relief Rally Won’t Last Long

MYL stock is currently priced high on hopes that it can limit damage over the EpiPen and return to normal. But is this hope enough for Mylan? More